|
0
|
|
Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's disease.
(linkinghub.elsevier.com)
|
Beckers M
…
Verbeek MM
EBioMedicine
2026-07-09
|
#neurodegeneration
#biomarker
#enzyme
#prodromal
#dopamine
|
|
0
|
|
The UFSP2-ODR4 complex spatially confines and dynamically controls UFM1 deconjugation to safeguard neuronal proteostasis.
(linkinghub.elsevier.com)
|
Mao G
…
Komatsu M
Molecular Cell
2026-07-09
|
#proteostasis
#ubiquitination
#neurodegeneration
#endoplasmic-reticulum
|
|
0
|
|
Beyond the gut: the multisite microbiota and its emerging role in brain health.
(tandfonline.com)
|
Jabbari Shiadeh SM
…
Ardalan M
Gut Microbes
2026-07-09
|
#microbiota
#neuroinflammation
#immunity
#neurodegeneration
#metabolomics
|
|
0
|
|
C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain.
(science.org)
|
Crowley G
…
Hong S
Science
2026-07-09
|
#synaptogenesis
#complement
#neuroinflammation
#neurodegeneration
#immunity
|
|
0
|
|
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial.
(nature.com)
|
Paul G
…
Barker RA
Nature Medicine
2026-07-09
|
#neurodegeneration
#stem-cells
#transplantation
#immunosuppression
#neuroprotection
|
|
0
|
|
NicheTrans: spatial-aware cross-omics translation.
(nature.com)
|
Wang Z
…
Yuan Z
Nature Methods
2026-07-09
|
#multi-omics
#spatial omics
#machine learning
#neurodegeneration
#proteomics
|
|
0
|
|
Recent advances in Alzheimer's disease: From molecular mechanisms to therapeutic strategies.
(linkinghub.elsevier.com)
|
Rudman MD
…
Holtzman DM
Cell
2026-07-09
|
#neurodegeneration
#biomarker
#neuroimmunology
#therapeutics
|